Literature DB >> 29203393

Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis.

Deepika Sharma1, Ankit Malik1, Clifford S Guy1, Rajendra Karki1, Peter Vogel2, Thirumala-Devi Kanneganti3.   

Abstract

BACKGROUND & AIMS: Inflammatory bowel diseases (IBD) increase risk for colorectal cancer. Mutations in the Mediterranean fever gene (MEFV or pyrin) are associated with hereditary autoinflammatory disease and severe IBD. Expression of MEFV, a sensor protein that the initiates assembly of the inflammasome complex, is increased in colon biopsies from patients with IBD. We investigated the role of pyrin in intestinal homeostasis in mice.
METHODS: Mefv-/- mice and C57/BL6 mice (controls) were given azoxymethane followed by multiple rounds of dextran sodium sulfate (DSS) to induce colitis and tumorigenesis. In some experiments, Mefv-/- mice were given injections of recombinant interleukin 18 (rIL18) or saline (control) during DSS administration. Colon tissues were collected at different time points during colitis development and analyzed by histology, immunohistochemistry, immunoblots, or ELISAs (to measure cytokines). Spleen and mesenteric lymph node were collected, processed, and analyzed by flow cytometry. Colon epithelial permeability was measured in mice with colitis by gavage of fluorescent dextran and quantification of serum levels.
RESULTS: MEFV was expressed in colons of control mice and expression increased during chronic and acute inflammation; high levels were detected in colon tumor and adjacent non-tumor tissues. Mefv-/- mice developed more severe colitis than control mice, with a greater extent of epithelial hyperplasia and a larger tumor burden. Levels of inflammatory cytokines (IL6) and chemokines were significantly higher in colons of Mefv-/- mice than control mice following colitis induction, whereas the level IL18, which depends on the inflammasome for maturation and release, was significantly lower in colons of Mefv-/- mice. Mefv-/- mice had increased epithelial permeability following administration of DSS than control mice, and loss of the tight junction proteins occludin and claudin-2 from intercellular junctions. STAT3 was activated (phosphorylated) in inflamed colon tissues from Mefv-/-, which also had increased expression of stem cell markers (OLFM4, BMI1, and MSI1) compared with colons from control mice. Administration of rIL18 to Mefv-/- mice reduced epithelial permeability, intestinal inflammation, the severity of colitis, and colon tumorigenesis.
CONCLUSIONS: In studies with DSS-induced colitis, we found that pyrin (MEFV) is required for inflammasome activation and IL18 maturation, which promote intestinal barrier integrity and prevent colon inflammation and tumorigenesis. Strategies to increase activity of MEFV or IL18 might be developed for the treatment of IBD and prevention of colitis-associated tumorigenesis.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Colitis-associated Cancer; Colon Cancer; Mouse Model; Tumor Suppressor

Mesh:

Substances:

Year:  2017        PMID: 29203393      PMCID: PMC5847456          DOI: 10.1053/j.gastro.2017.11.276

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  67 in total

1.  MEFV gene mutations and its impact on the clinical course in ulcerative colitis patients.

Authors:  Beytullah Yıldırım; Candan Tuncer; Derya Kan; Bilge Tunc; Mehmet Derya Demirag; E Ferda Percın; Seminur Haznedaroglu; Hakan Alagozlu
Journal:  Rheumatol Int       Date:  2010-03-12       Impact factor: 2.631

2.  A functional role for Nlrp6 in intestinal inflammation and tumorigenesis.

Authors:  Grace Y Chen; Maochang Liu; Fuyuan Wang; John Bertin; Gabriel Núñez
Journal:  J Immunol       Date:  2011-05-04       Impact factor: 5.422

3.  The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer.

Authors:  Irving C Allen; Erin McElvania TeKippe; Rita-Marie T Woodford; Joshua M Uronis; Eda K Holl; Arlin B Rogers; Hans H Herfarth; Christian Jobin; Jenny P-Y Ting
Journal:  J Exp Med       Date:  2010-04-12       Impact factor: 14.307

4.  Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis.

Authors:  Liping Su; Le Shen; Daniel R Clayburgh; Sam C Nalle; Erika A Sullivan; Jon B Meddings; Clara Abraham; Jerrold R Turner
Journal:  Gastroenterology       Date:  2008-11-06       Impact factor: 22.682

5.  MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18.

Authors:  Rosalba Salcedo; Andrea Worschech; Marco Cardone; Yava Jones; Zsofia Gyulai; Ren-Ming Dai; Ena Wang; Winnie Ma; Diana Haines; Colm O'hUigin; Francesco M Marincola; Giorgio Trinchieri
Journal:  J Exp Med       Date:  2010-07-12       Impact factor: 14.307

Review 6.  Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer.

Authors:  Jonathan Landy; Emma Ronde; Nick English; Sue K Clark; Ailsa L Hart; Stella C Knight; Paul J Ciclitira; Hafid Omar Al-Hassi
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

7.  NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion.

Authors:  Marta Wlodarska; Christoph A Thaiss; Roni Nowarski; Jorge Henao-Mejia; Jian-Ping Zhang; Eric M Brown; Gad Frankel; Maayan Levy; Meirav N Katz; William M Philbrick; Eran Elinav; B Brett Finlay; Richard A Flavell
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

8.  Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation.

Authors:  Liqin Zhu; Paul Gibson; D Spencer Currle; Yiai Tong; Robert J Richardson; Ildar T Bayazitov; Helen Poppleton; Stanislav Zakharenko; David W Ellison; Richard J Gilbertson
Journal:  Nature       Date:  2008-12-17       Impact factor: 49.962

Review 9.  Organoids as a Model for Colorectal Cancer.

Authors:  Madeleine Young; Karen R Reed
Journal:  Curr Colorectal Cancer Rep       Date:  2016-08-06

10.  NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer.

Authors:  Rajendra Karki; Si Ming Man; R K Subbarao Malireddi; Sannula Kesavardhana; Qifan Zhu; Amanda R Burton; Bhesh Raj Sharma; Xiaopeng Qi; Stephane Pelletier; Peter Vogel; Philip Rosenstiel; Thirumala-Devi Kanneganti
Journal:  Nature       Date:  2016-12-12       Impact factor: 49.962

View more
  45 in total

Review 1.  NLRP3 inflammasome in cancer and metabolic diseases.

Authors:  Bhesh Raj Sharma; Thirumala-Devi Kanneganti
Journal:  Nat Immunol       Date:  2021-03-11       Impact factor: 25.606

Review 2.  Let's get this pyrin started!

Authors:  Emilia Liana Falcone; Clare Bryant
Journal:  J Biol Chem       Date:  2019-03-08       Impact factor: 5.157

3.  Transient High Pressure in Pancreatic Ducts Promotes Inflammation and Alters Tight Junctions via Calcineurin Signaling in Mice.

Authors:  Li Wen; Tanveer A Javed; Dean Yimlamai; Amitava Mukherjee; Xiangwei Xiao; Sohail Z Husain
Journal:  Gastroenterology       Date:  2018-06-19       Impact factor: 22.682

Review 4.  The pyrin inflammasome and the Yersinia effector interaction.

Authors:  Haleema S Malik; James B Bliska
Journal:  Immunol Rev       Date:  2020-07-28       Impact factor: 12.988

Review 5.  The pyrin inflammasome in host-microbe interactions.

Authors:  Nicole A Loeven; Natasha P Medici; James B Bliska
Journal:  Curr Opin Microbiol       Date:  2020-02-28       Impact factor: 7.934

Review 6.  Inflammasome activation and regulation: toward a better understanding of complex mechanisms.

Authors:  Danping Zheng; Timur Liwinski; Eran Elinav
Journal:  Cell Discov       Date:  2020-06-09       Impact factor: 10.849

7.  Bile acid analogues are activators of pyrin inflammasome.

Authors:  Irina Alimov; Suchithra Menon; Nadire Cochran; Rob Maher; Qiong Wang; John Alford; John B Concannon; Zinger Yang; Edmund Harrington; Luis Llamas; Alicia Lindeman; Gregory Hoffman; Tim Schuhmann; Carsten Russ; John Reece-Hoyes; Stephen M Canham; Xinming Cai
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

8.  TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy.

Authors:  Deepika Sharma; Ankit Malik; Clifford Guy; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

9.  Intracellular innate immune receptors: Life inside the cell.

Authors:  Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2020-09       Impact factor: 12.988

10.  A comprehensive guide to studying inflammasome activation and cell death.

Authors:  Rebecca E Tweedell; R K Subbarao Malireddi; Thirumala-Devi Kanneganti
Journal:  Nat Protoc       Date:  2020-09-07       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.